FDA Inspection
Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc. – FDA Inspection, Jan 16, 2026
Record Details
This FDA Inspection record concerns Regeneron Pharmaceuticals, Inc., with an inspection on January 16, 2026, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 80f1263d-d05f-4449-b8b0-4d7778eba110
Inspection Facts
- Inspection number
- 1291552
- FDA center
- Human Drugs
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.